P Parfrey
Overview
Explore the profile of P Parfrey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
249
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Parfrey P, Sheehan J
Ir J Med Sci
. 2016 Aug;
144(1):335.
PMID: 27518979
Heart rate (HR) and forearm blood flow (FBF) during 30 sec. breath holding (BH) were recorded in 10 healthy men. (1) during whole face immersion (FI) in water between 5...
2.
Warden G, Harnett D, Green J, Wish T, Woods M, Green R, et al.
Clin Genet
. 2013 Jan;
84(6):522-30.
PMID: 23278430
Hereditary non-polyposis colorectal cancer (HNPCC) may be the result of Lynch syndrome (LS) caused by mutations in mismatch repair (MMR) genes, a syndrome of unknown etiology called familial colorectal cancer...
3.
Ju W, Zhong R, Moore S, Moroziewicz D, Currie J, Parfrey P, et al.
J Med Genet
. 2002 Nov;
39(11):822-5.
PMID: 12414822
No abstract available.
4.
Rigatto C, Parfrey P
Perit Dial Int
. 2002 Mar;
21 Suppl 3:S275-9.
PMID: 11887835
Cardiomyopathy and IHD are important morbid complications among renal transplant recipients. Age, diabetes, and sex remain important markers of risk. Smoking, hyperlipidemia, and hypertension appear to be the major reversible...
5.
Parfrey P
Nephrol Dial Transplant
. 2001 Oct;
16 Suppl 7:41-5.
PMID: 11590256
Cardiovascular disease is the major cause of death among patients with end-stage renal disease, accounting for almost half of all fatalities. In recent years much progress has been made in...
6.
Pei Y, Paterson A, Wang K, He N, Hefferton D, Watnick T, et al.
Am J Hum Genet
. 2001 Jan;
68(2):355-63.
PMID: 11156533
In searching for a putative third gene for autosomal dominant polycystic kidney disease (ADPKD), we studied the genetic inheritance of a large family (NFL10) previously excluded from linkage to both...
7.
Watnick T, He N, Wang K, Liang Y, Parfrey P, Hefferton D, et al.
Nat Genet
. 2000 Jun;
25(2):143-4.
PMID: 10835625
Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in PKD1 and PKD2. The products of these genes associate to form heteromeric complexes. Several models have been proposed to...
8.
Turner C, Parfrey P, Ryan K, Miller R, Brown A
Am J Health Syst Pharm
. 2000 Apr;
57(8):747-52.
PMID: 10786260
The predictive value of digoxin and furosemide treatment for identifying patients receiving treatment for congestive heart failure (CHF), the use of angiotensin-converting-enzyme (ACE) inhibitors in this population, and the ability...
9.
Pei Y, Watnick T, He N, Wang K, Liang Y, Parfrey P, et al.
J Am Soc Nephrol
. 1999 Jul;
10(7):1524-9.
PMID: 10405208
An intriguing feature of autosomal dominant polycystic kidney disease (ADPKD) is the focal and sporadic formation of renal and extrarenal cysts. Recent documentation of somatic PKD1 mutations in cystic epithelia...
10.
Pei Y, He N, Wang K, Kasenda M, Paterson A, Chan G, et al.
J Am Soc Nephrol
. 1998 Oct;
9(10):1853-60.
PMID: 9773786
Autosomal dominant polycystic kidney disease (ADPKD) is a common Mendelian disorder that affects approximately 1 in 1000 live births. Linkage studies have shown that the majority (approximately 85%) of cases...